New hope for pancreatic cancer patients after FDA approves drug shown to improve survival

Pancreatic cancer is among the deadliest forms, largely because detection is difficult before malignancy spreads to other organs

WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer.

The drug, branded as Rasonque and also known as daraxonrasib, is a once-daily pill designed to block several forms of the RAS protein, which helps drive tumor growth in many pancreatic cancers.

FDA officials approve first-of-a-kind pill called daraxonrasib to fight one of the deadliest types of cancer The US Food and Drug Administration (FDA) approved a groundbreaking new drug for the most common form of pancreatic cancer, offering US patients a more effective treatment against one of the deadliest types of t

Patients taking the drug nearly doubled their survival time, with fewer severe side effects, in a study that randomly assigned them to receive the experimental treatment or more chemotherapy.

The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer.

Daraxonrasib made headlines earlier this year when former US Sen. Ben Sasse, R-Neb., shared details about his experience with the drug — which left his skin bloody and “bubbling” but is giving him more time with his family.

WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer. FDA officials gave expedited approval to the first-of-a-kind pill, called dara

Pancreatic cancer is considered one of the hardest to treat and most serious cancers

U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer

FDA approves landmark pancreatic cancer drug that’s shown to improve survival  AP News

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque  Forbes

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug  CNN

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

FDA Approves Drug for Pancreatic Cancer in Incredible Moment for Deadly Disease  WSJ

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug  Reuters

The FDA has approved a life-extending treatment for advanced pancreatic cancer — the first such therapy to attack a genetic cause of the highly lethal malignancy.

Sussex mum with breast cancer hails breakthrough drug for 'new lease of life' | ITV News  ITVX

The issue has become a political one in recent weeks, with opposition politicians calling for the HSE to approve the funding of the drug.

People suffering from rare disease ‘beg’ for life-changing medicine